Blue Water Life Science Advisors’s Personalis PSNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Hold
1,676,300
8.56% 6
2025
Q4
$13.3M Hold
1,676,300
8.37% 4
2025
Q3
$10.9M Hold
1,676,300
9.97% 4
2025
Q2
$11M Buy
1,676,300
+500,900
+43% +$2.33M 8.7% 6
2025
Q1
$4.13M Buy
1,175,400
+42,500
+4% +$202K 4.09% 6
2024
Q4
$6.55M Buy
1,132,900
+132,900
+13% +$613K 5.8% 6
2024
Q3
$5.38M Buy
+1,000,000
New +$4.12M 4.73% 7

Other funds holding PSNL

Blue Water Life Science Advisors's PSNL Position: Q1 2026 in Review

Blue Water Life Science Advisors held its Personalis (PSNL) position steady in Q1 2026 at 1,676,300 shares worth $10.7M. The position accounts for 8.56% of the portfolio, ranked #6.

Blue Water Life Science Advisors first reported a position in PSNL in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.3M in Q4 2025. 140 funds tracked by Wall St. Rank hold PSNL as of Q1 2026.

  • Blue Water Life Science Advisors held 1,676,300 shares of Personalis worth $10.7M as of Q1 2026.
  • Blue Water Life Science Advisors left its Personalis share count unchanged in Q1 2026.
  • Personalis made up 8.56% of Blue Water Life Science Advisors's portfolio in Q1 2026, its #6 holding.
  • Blue Water Life Science Advisors first reported a position in Personalis in Q3 2024 and has held it in 7 quarters since.
  • Blue Water Life Science Advisors's Personalis position peaked at $13.3M in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Personalis as of Q1 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2026, filed 14 May 2026.